Bioanalysis is determining the concentration of drugs and metabolites in biological fluids (i.e. plasma and urine) . During the past 15years tremendous advances in bioanalysis, for example HPLC, auto injectors, data collection systems and robotics has enabled the productivity of,the bioanalyst to increase but it still requires considerable manual intervention. This paper describes the rationale, the justification and the plans Bristol-Myers If the entire bioanalytical process were to be automated at Bristol-Myers Squibb, the goals would be:
( (4) Improve analyst safety from blood-born diseases and be able to bring HIV+ samples in-house for bioanalysis.
(5) Maximize the time that expensive equipment is utilized by continuously feeding it samples.
(6) Accelerate drug development by processing samples at a faster rate.
(7) Improve our sample tracking capabilities that are often done manually.
(8) Improve worker morale.
A 40 ft x 100 ft automation bioanalytical laboratory that addresses all of the sample processing steps described in figure is shown in figure 2 
